Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Race Oncology Ltd. (AU:RAC)
ASX:RAC
RESEARCH TOOLSreports
Race Oncology Ltd. (RAC) Share Price & Analysis
4 Followers
RAC Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.64 - AU$2.01
Previous CloseAU$1.42
Volume11.16K
Average Volume (3M)143.82K
Market Cap
AU$234.54M
Enterprise ValueAU$201.00M
Total Cash (Recent Filing)AU$33.54M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)-20.8
Beta0.73
Next Earnings
Aug 23, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding164,778,179
10 Day Avg. Volume231,853
30 Day Avg. Volume143,825
Standard Deviation0.25
R-Squared0.02
Alpha0.06
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
27.16%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
72.84% Public Companies and
Individual Investors
RAC FAQ
What was Race Oncology Ltd.’s price range in the past 12 months?
Race Oncology Ltd. lowest share price was AU$0.64 and its highest was AU$2.01 in the past 12 months.
What is Race Oncology Ltd.’s market cap?
Currently, no data Available
When is Race Oncology Ltd.’s upcoming earnings report date?
Race Oncology Ltd.’s upcoming earnings report date is Aug 23, 2024 which is in 127 days.
How were Race Oncology Ltd.’s earnings last quarter?
Race Oncology Ltd. released its earnings results on Feb 27, 2024. The company reported -AU$0.035 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.035.
Is Race Oncology Ltd. overvalued?
According to Wall Street analysts Race Oncology Ltd.’s price is currently Overvalued.
Does Race Oncology Ltd. pay dividends?
Race Oncology Ltd. does not currently pay dividends.
What is Race Oncology Ltd.’s EPS estimate?
Race Oncology Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Race Oncology Ltd. have?
Race Oncology Ltd. has 165,172,030 shares outstanding.
What happened to Race Oncology Ltd.’s price movement after its last earnings report?
Race Oncology Ltd. reported an EPS of -AU$0.035 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Race Oncology Ltd.?
Currently, no hedge funds are holding shares in AU:RAC
---
Race Oncology Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:RAC Sentiment 98%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-19.77%
12-Months-Change
Fundamentals
Return on Equity
-43.67%
Trailing 12-Months
Asset Growth
-33.30%
Trailing 12-Months
Company Description
Race Oncology Ltd.
Race Oncology Ltd is a specialty pharmaceutical company. It is engaged in the development and marketing of pharmaceutical drugs for the treatment of Cancer. Its product includes Bisantrene, a cancer chemotherapy drug. Its operating segments include research into oncology drugs, Zantrene and the manufacturing and distribution of the drug for clinical trials.
---
Technical Analysis
---